214 related articles for article (PubMed ID: 32733369)
1. Translational Windows in Chordoma: A Target Appraisal.
Hoffman SE; Al Abdulmohsen SA; Gupta S; Hauser BM; Meredith DM; Dunn IF; Bi WL
Front Neurol; 2020; 11():657. PubMed ID: 32733369
[TBL] [Abstract][Full Text] [Related]
2. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
3. Challenges of local recurrence and cure in low grade malignant tumors of the spine.
Boriani S; Saravanja D; Yamada Y; Varga PP; Biagini R; Fisher CG
Spine (Phila Pa 1976); 2009 Oct; 34(22 Suppl):S48-57. PubMed ID: 19829277
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde Dehydrogenase, a Therapeutic Target in Chordoma: Analysis in 3D Cellular Models.
Locquet MA; Dechaume AL; Berchard P; Abbes L; Pissaloux D; Tirode F; Ramos I; Bedoucha J; Valantin J; Karanian M; Perret R; Gille O; Blay JY; Dutour A
Cells; 2021 Feb; 10(2):. PubMed ID: 33672032
[TBL] [Abstract][Full Text] [Related]
5. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
[TBL] [Abstract][Full Text] [Related]
6. Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas.
Han S; Polizzano C; Nielsen GP; Hornicek FJ; Rosenberg AE; Ramesh V
Clin Cancer Res; 2009 Mar; 15(6):1940-6. PubMed ID: 19276265
[TBL] [Abstract][Full Text] [Related]
7. Surgical Resection and Adjuvant Radiation Therapy in the Treatment of Skull Base Chordomas.
Sanusi O; Arnaout O; Rahme RJ; Horbinski C; Chandler JP
World Neurosurg; 2018 Jul; 115():e13-e21. PubMed ID: 29545225
[TBL] [Abstract][Full Text] [Related]
8. Current therapeutic options and novel molecular markers in skull base chordomas.
Gagliardi F; Boari N; Riva P; Mortini P
Neurosurg Rev; 2012 Jan; 35(1):1-13; discussion 13-4. PubMed ID: 22006091
[TBL] [Abstract][Full Text] [Related]
9. Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.
Gill CM; Fowkes M; Shrivastava RK
Neurosurgery; 2020 Feb; 86(2):E118-E123. PubMed ID: 31504814
[TBL] [Abstract][Full Text] [Related]
10. Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience.
Molina CA; Ames CP; Chou D; Rhines LD; Hsieh PC; Zadnik PL; Wolinsky JP; Gokaslan ZL; Sciubba DM
J Neurosurg Spine; 2014 Sep; 21(3):348-56. PubMed ID: 24926926
[TBL] [Abstract][Full Text] [Related]
11. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.
Gokaslan ZL; Zadnik PL; Sciubba DM; Germscheid N; Goodwin CR; Wolinsky JP; Bettegowda C; Groves ML; Luzzati A; Rhines LD; Fisher CG; Varga PP; Dekutoski MB; Clarke MJ; Fehlings MG; Quraishi NA; Chou D; Reynolds JJ; Williams RP; Kawahara N; Boriani S
J Neurosurg Spine; 2016 Apr; 24(4):644-51. PubMed ID: 26682601
[TBL] [Abstract][Full Text] [Related]
12. The molecular aspects of chordoma.
Gulluoglu S; Turksoy O; Kuskucu A; Ture U; Bayrak OF
Neurosurg Rev; 2016 Apr; 39(2):185-96; discussion 196. PubMed ID: 26363792
[TBL] [Abstract][Full Text] [Related]
13. Review of current treatment of sacral chordoma.
Chen KW; Yang HL; Kandimalla Y; Liu JY; Wang GL
Orthop Surg; 2009 Aug; 1(3):238-44. PubMed ID: 22009849
[TBL] [Abstract][Full Text] [Related]
14. The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies.
Xu J; Shi Q; Wang B; Ji T; Guo W; Ren T; Tang X
Front Immunol; 2023; 14():1257254. PubMed ID: 37720221
[TBL] [Abstract][Full Text] [Related]
15. Spinal chordomas dedifferentiated to osteosarcoma: a report of two cases and a literature review.
Kato S; Gasbarrini A; Ghermandi R; Gambarotti M; Bandiera S
Eur Spine J; 2016 May; 25 Suppl 1():251-6. PubMed ID: 27052403
[TBL] [Abstract][Full Text] [Related]
16. Primary chordomas of the cervical spine: a consecutive series of 14 surgically managed cases.
Wang Y; Xiao J; Wu Z; Huang Q; Huang W; Zhu Q; Lin Z; Wang L
J Neurosurg Spine; 2012 Oct; 17(4):292-9. PubMed ID: 22920610
[TBL] [Abstract][Full Text] [Related]
17. Chordomas of the craniocervical junction: follow-up review and prognostic factors.
Colli B; Al-Mefty O
J Neurosurg; 2001 Dec; 95(6):933-43. PubMed ID: 11765837
[TBL] [Abstract][Full Text] [Related]
18. Management and outcome of chordomas in the pediatric population: The Hospital for Sick Children experience and review of the literature.
Tsitouras V; Wang S; Dirks P; Drake J; Bouffet E; Hawkins C; Laughlin S; Rutka JT
J Clin Neurosci; 2016 Dec; 34():169-176. PubMed ID: 27590862
[TBL] [Abstract][Full Text] [Related]
19. Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence.
Ito E; Saito K; Okada T; Nagatani T; Nagasaka T
Acta Neurochir (Wien); 2010 Jan; 152(1):57-67; discussion 67. PubMed ID: 19826755
[TBL] [Abstract][Full Text] [Related]
20. Chordomas of the skull base: follow-up review and prognostic factors.
Colli BO; Al-Mefty O
Neurosurg Focus; 2001 Mar; 10(3):E1. PubMed ID: 16734401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
